相似文献
1
Is fecal DNA testing superior to fecal occult-blood testing for colorectal cancer screening?
Nat Clin Pract Oncol. 2005 May;2(5):234-5. doi: 10.1038/ncponc0170.
2
Colon cancer screening strategies.
Curr Opin Gastroenterol. 2005 Jan;21(1):59-63.
3
Fecal DNA for noninvasive diagnosis of colorectal cancer in immunochemical fecal occult blood test-positive individuals.
Cancer Epidemiol Biomarkers Prev. 2010 Oct;19(10):2647-54. doi: 10.1158/1055-9965.EPI-10-0291.
4
Screening with a fecal multitarget DNA test.
Gastroenterology. 2005 Aug;129(2):757-9; discussion 759. doi: 10.1016/j.gastro.2005.04.039.
5
Fecal DNA for colorectal-cancer screening.
N Engl J Med. 2005 Mar 31;352(13):1384-5; author reply 1384-5. doi: 10.1056/NEJM200503313521323.
6
Improved fecal DNA test for colorectal cancer screening.
Clin Gastroenterol Hepatol. 2007 Jan;5(1):111-7. doi: 10.1016/j.cgh.2006.10.006. Epub 2006 Dec 8.
7
Fecal DNA for colorectal-cancer screening.
N Engl J Med. 2005 Mar 31;352(13):1384-5; author reply 1384-5.
8
Fecal DNA biomarkers for the detection of colorectal neoplasia: attractive, but is it feasible?
J Natl Cancer Inst. 2005 Aug 3;97(15):1107-9. doi: 10.1093/jnci/dji244.
9
A smarter strategy? Reflections on fecal DNA screening for colorectal cancer.
N Engl J Med. 2004 Dec 23;351(26):2755-8. doi: 10.1056/NEJMe048259.
10
[Fecal methylated DNA for the detection of colorectal cancer].
Z Gastroenterol. 2006 Sep;44(9):1001-2. doi: 10.1055/s-2006-927124.
引用本文的文献
1
What is a Reasonable Screening Test for Colorectal Cancer.
J Korean Soc Coloproctol. 2010 Dec;26(6):375. doi: 10.3393/jksc.2010.26.6.375. Epub 2010 Dec 31.
2
Long-range epigenetic silencing at 2q14.2 affects most human colorectal cancers and may have application as a non-invasive biomarker of disease.
Br J Cancer. 2009 May 19;100(10):1534-9. doi: 10.1038/sj.bjc.6605045. Epub 2009 Apr 21.
Zotero 插件